Business · 30/08/1994Updated: 10/18/2026 · 1 min read
FDA Announces Intent to Award Grant for Orphan Drug to American Drug Development, Inc.
Summary
The FDA is considering a grant application from ADD to provide Sodium Phenylbutyrate to children with three fatal urea cycle disorders, as the company is the sole manufacturer and supplier of the drug for this treatment.
Original source language: Federal Register — Health and Human ServicesOpen original release →